SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-057515
Filing Date
2008-09-08
Accepted
2008-09-08 15:58:35
Documents
4
Period of Report
2008-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-22870_18k.htm 8-K 42235
2 EX-10.1 a08-22870_1ex10d1.htm EX-10.1 466765
3 EX-99.1 a08-22870_1ex99d1.htm EX-99.1 16124
4 GRAPHIC g228701mm01i001.jpg GRAPHIC 2937
  Complete submission text file 0001104659-08-057515.txt   531194
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 081061046
SIC: 2835 In Vitro & In Vivo Diagnostic Substances